Maria Cristina Pedrazini

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Combination Therapy

Herpes Simplex Virus

Top Venues

Dermatologic therapy

Clinical, cosmetic and investigational dermatology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Victor Augusto Benedicto Dos Santos, Maria Cristina Pedrazini
L-lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Letter]. Clinical, cosmetic and investigational dermatology 17 (2024)
Victor Augusto Benedicto Dos Santos, Maria Cristina Pedrazini
L-lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Letter]. Clinical, cosmetic and investigational dermatology 17 (2024)
Victor Augusto Benedicto Dos Santos, Maria Cristina Pedrazini
L-lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Letter]. Clinical, cosmetic and investigational dermatology 17 (2024)
Maria Cristina Pedrazini, Mariliza Henrique da Silva, Francisco Carlos Groppo
L-lysine in herpesvirus reactivation after ChAdOx1 nCoV-19 vaccine (AZD1222): Minor literature review and case report. Dermatologic therapy 35 (3) (2022)
Maria Cristina Pedrazini, Mariliza Henrique da Silva, Francisco Carlos Groppo
L-lysine: Its antagonism with L-arginine in controlling viral infection. Narrative literature review. British journal of clinical pharmacology 88 (11) (2022)
Maria Cristina Pedrazini, Mariliza Henrique da Silva
Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review. Dermatologic therapy 34 (6) (2021)
Maria Cristina Pedrazini, Francisco Carlos Groppo
L-lysine therapy to control the clinical evolution of pityriasis rosea: Clinical case report and literature review. Dermatologic therapy 34 (1) (2020)